Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference15 articles.
1. Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B;Manning;Br. J. Pharmacol.,1999
2. Antipruritic effect of the topical phosphodiesterase 4 inhibitor E6005 ameliorates skin lesions in a mouse atopic dermatitis model;Ishii;J. Pharmacol. Exp. Ther.,2013
3. JAPANESE E6005 Study Investigators, Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: results of a randomized, vehicle-controlled, multicenter clinical trial;Furue;J. Dermatol.,2014
4. State-of-the-art dried blood spot analysis: an overview of recent advances and future trends;Meesters;Bioanalysis,2013
5. Validation of a UPLC-MS/MS method for the simultaneous determination of E6005 a phosphodiesterase 4 inhibitor, and its metabolite in human plasma;Mano;J Chromatogr. B Anal. Technol. Biomed. Life Sci.,2015
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献